Abstract
Letters and Corrections1 January 1980Serum Aluminum and Continuous Ambulatory Peritoneal DialysisA. WOLF, M.D., H. GRAF, M.D., W. F. PINGGERA, M.D., H. K. STUMMVOLL, M.D., V. MEISINGER, M.D.A. WOLF, M.D.Search for more papers by this author, H. GRAF, M.D.Search for more papers by this author, W. F. PINGGERA, M.D.Search for more papers by this author, H. K. STUMMVOLL, M.D.Search for more papers by this author, V. MEISINGER, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-92-1-130_2 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: Accumulation of aluminum in the blood and tissues of patients maintained on chronic hemodialysis may cause "dialysis dementia," frequently leading to death (1). The aluminum content of the dialysis bath fluid or the aluminum-hydroxide (Al [OH]3) gels taken by dialysis patients are responsible for the hyperalbuminemia and the high aluminum body stores (2, 3). In the past 4 years continuous ambulatory peritoneal dialysis has been established in the treatment of patients with end-stage renal disease. To our knowledge no information exists on aluminum kinetics in patients thus treated.We have measured serum aluminum and aluminum clearances in...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
